Literature DB >> 23211702

Two novel mutations of the GTP cyclohydrolase 1 gene and genotype-phenotype correlation in Chinese Dopa-responsive dystonia patients.

Lihua Yu1, Huayong Zhou, Fayun Hu, Yanming Xu.   

Abstract

The most common form of Dopa-responsive dystonia (DRD) is caused by heterozygous mutations in the GTP cyclohydrolase I (GCH1) gene. We screened two unrelated, DRD-symptomatic Chinese Han individuals, for GCH1 gene mutations by direct sequencing. As the clinical manifestations of DRD are highly variable, we also explored the association between genotype and phenotype in all Chinese DRD patients reported so far in the literature, comprising 62 DRD-affected patients from 36 Chinese families. Two novel missense mutations (T94M, L145F) and a novel variant (c. 453+6 G>T) were identified in our two new patients. None of these variants was detected in 200 healthy controls. On the basis of this and other reports, heterozygous mutations were detected in 90.3% of Chinese Han subjects with DRD. Seeming the age of onset for males and females, the mean age was 13 years older in males than in females (P=0.006). Different mutation types did not show any significant differences in age of onset, gender composition, initial symptoms, or the L-dopa dose that abolished the symptoms. Among DRD patients lacking missense or exon-intron boundary mutations, 68.4% were found to possess a large deletion in GCH1, which were detected by multiplex ligation-dependent probe amplification. Most GCH1 mutations were found to cluster in two regions of the coding sequence, suggesting the probable existence of mutation hotspot for the first time. The genotype-phenotype correlation described here may improve our understanding of DRD in Chinese individuals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23211702      PMCID: PMC3722942          DOI: 10.1038/ejhg.2012.239

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  18 in total

Review 1.  Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.

Authors:  Yoshiaki Furukawa
Journal:  Adv Neurol       Date:  2004

2.  Hereditary progressive dystonia with marked diurnal fluctuation.

Authors:  M Segawa; A Hosaka; F Miyagawa; Y Nomura; H Imai
Journal:  Adv Neurol       Date:  1976

Review 3.  Dopa-responsive dystonia.

Authors:  T G Nygaard; C D Marsden; R C Duvoisin
Journal:  Adv Neurol       Date:  1988

4.  Dopa-responsive dystonia: mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa. German Dystonia Study Group.

Authors:  D Steinberger; R Korinthenberg; H Topka; M Berghäuser; R Wedde; U Müller
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

5.  GCH1 mutation in a patient with adult-onset oromandibular dystonia.

Authors:  D Steinberger; H Topka; D Fischer; U Müller
Journal:  Neurology       Date:  1999-03-10       Impact factor: 9.910

6.  A novel missense mutation in GTP cyclohydrolase I (GCH1) gene causes Dopa-responsive dystonia in Chinese Han population.

Authors:  F-Y Hu; Y-M Xu; L-H Yu; M-Y Ma; X-H He; D Zhou
Journal:  Eur J Neurol       Date:  2011-02       Impact factor: 6.089

7.  High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screening.

Authors:  J Hagenah; R Saunders-Pullman; K Hedrich; K Kabakci; K Habermann; K Wiegers; K Mohrmann; T Lohnau; D Raymond; P Vieregge; T Nygaard; L J Ozelius; S B Bressman; C Klein
Journal:  Neurology       Date:  2005-03-08       Impact factor: 9.910

8.  Heterozygous mutation in 5'-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia.

Authors:  Daniela Steinberger; Nenad Blau; Dimitri Goriuonov; Juliane Bitsch; Michael Zuker; Sibylla Hummel; Ulrich Müller
Journal:  Neurogenetics       Date:  2004-07-06       Impact factor: 2.660

9.  Dopa-responsive dystonia: a clinical and molecular genetic study.

Authors:  O Bandmann; E M Valente; P Holmans; R A Surtees; J H Walters; R A Wevers; C D Marsden; N W Wood
Journal:  Ann Neurol       Date:  1998-10       Impact factor: 10.422

10.  Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia.

Authors:  T G Nygaard; H Takahashi; G A Heiman; B J Snow; S Fahn; D B Calne
Journal:  Ann Neurol       Date:  1992-11       Impact factor: 10.422

View more
  4 in total

Review 1.  Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies.

Authors:  Thomas Opladen; Eduardo López-Laso; Elisenda Cortès-Saladelafont; Toni S Pearson; H Serap Sivri; Yilmaz Yildiz; Birgit Assmann; Manju A Kurian; Vincenzo Leuzzi; Simon Heales; Simon Pope; Francesco Porta; Angeles García-Cazorla; Tomáš Honzík; Roser Pons; Luc Regal; Helly Goez; Rafael Artuch; Georg F Hoffmann; Gabriella Horvath; Beat Thöny; Sabine Scholl-Bürgi; Alberto Burlina; Marcel M Verbeek; Mario Mastrangelo; Jennifer Friedman; Tessa Wassenberg; Kathrin Jeltsch; Jan Kulhánek; Oya Kuseyri Hübschmann
Journal:  Orphanet J Rare Dis       Date:  2020-05-26       Impact factor: 4.123

2.  GTP cyclohydrolase I and tyrosine hydroxylase gene mutations in familial and sporadic dopa-responsive dystonia patients.

Authors:  Chunyou Cai; Wentao Shi; Zheng Zeng; Meiyun Zhang; Chao Ling; Lei Chen; Chunquan Cai; Benshu Zhang; Wei-Dong Li
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

3.  A Genome-Wide mRNA Screen and Functional Analysis Reveal FOXO3 as a Candidate Gene for Chicken Growth.

Authors:  Biao Chen; Jiguo Xu; Xiaomei He; Haiping Xu; Guihuan Li; Hongli Du; Qinghua Nie; Xiquan Zhang
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

Review 4.  Atypical presentation of dopa-responsive dystonia in Taiwan.

Authors:  Yi Ching Weng; Chun Chieh Wang; Yih Ru Wu
Journal:  Brain Behav       Date:  2018-01-20       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.